View Post

Polio Outbreaks Remain Global Health Risk in 2024

In COVID-19, Latest News by Precision Vaccinations

The 37th meeting of the World Health Organization (WHO) Emergency Committee under the International Health Regulations on the international spread of poliovirus was convened on December 12, 2023.
The WHO's Committee unanimously agreed that the risk of the international spread of poliovirus remains a Public Health Emergency of International Concern and recommended its extension and Temporary Recommendations for a further three months.
In 2022, the United States was added to this list of countries where polio was identified.  

View Post

Infants Protected From RSV Hospitalizations With Passive Immunization

In COVID-19, Latest News by Precision Vaccinations

An Original Article published today reported a second-generation monoclonal antibody (mAb) reduced hospitalizations among infants with respiratory syncytial virus (RSV)-associated lower respiratory tract infection.
The recently approved single-dose Beyfortus™ (nirsevimab) was found in a phase 3 clinical study that (0.3%) of infants who received Beyfortus were hospitalized for RSV-associated lower respiratory tract infection compared with 1.5% of those who received standard care.

View Post

Will Texas Encounter Dengue Outbreaks in 2024

In COVID-19, Latest News by Precision Vaccinations

The global outbreak of dengue has significantly increased over the past two decades. From 2000 to 2019, the World Health Organization (WHO) documented a ten-fold surge in dengue cases.
According to the WHO Disease Outbreak News (DON498) published on December 21, 2023, this year's dengue upsurge has been characterized by a significant increase in the scale and simultaneous occurrence.
Moreover, the mosquito-transmitted disease impacts regions previously unaffected by dengue as the range of Aedes aegypti and Aedes albopictus mosquitoes increases.